Pulmonary aspergillosis—a group of infectious respiratory diseases caused by various species of the fungus Aspergillus fumigatus—has a significant mortality rate globally. Currently, the first-line antifungal therapy ...
Nov 9, 2023
0
0
Fungi such as Aspergillus are so common in our surroundings that we breathe in hundreds to thousands of spores every day. In healthy people, fungi typically pose no threat, but they can cause deadly infections in those with ...
Jan 12, 2023
0
142
Treatment for fungal lung infections could be more efficient when medication is inhaled using nanoparticle technology, according to research from the University of Central Lancashire (UCLan).
May 21, 2021
0
10
(Medical Xpress)—As winter approaches doctors are warning that wet washing dried indoors can pose a serious health threat for people with weakened immune systems or severe asthma.
Nov 27, 2014
1
0
A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone ...
Jul 24, 2014
0
0
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
May 8, 2013
0
0
Researchers have discovered that over a million people worldwide diagnosed with TB go on to develop an incurable but manageable fungal infection which is usually left untreated because it is mistaken for a recurrence of the ...
Dec 1, 2011
0
0
